Auroa Badin, MD
Clinical Cardiac Electrophysiology · Columbus, OHNPI 1790097376
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Boston Scientific at 32.3% of the total. 2025 is the largest year on record at $84,559, more than ten times the $2,304 reported in 2019. Among clinical cardiac electrophysiology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 426 payments — averaging $440.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$61K
- Siemens Medical Solutions USA, Inc.$47K
- Philips North America LLC$38K
- Biosense Webster, Inc.$25K
- Medtronic$9K
- Abbott$5K
- plus $3K from 4 others
Across 9 payments — averaging $43,642 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$393K
What the payments were for
- Consulting fees$68,43036%
- Speaking & faculty fees$78,31142%
- Travel & lodging$24,81313%
- Food & beverage$15,9809%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 151 | $60,558 |
| Siemens Medical Solutions USA, Inc. | 38 | $46,566 |
| Philips North America LLC | 56 | $38,404 |
| Biosense Webster, Inc. | 59 | $25,163 |
| Medtronic(2 entities) | 67 | $9,096 |
| Abbott | 47 | $5,224 |
| Medical Device Business Services, Inc. | 4 | $2,438 |
| E.r. Squibb & Sons, L.L.C. | 2 | $38 |
| Kestra Medical Technology Services, Inc. | 1 | $34 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (9520) IGT Devices Undivided$26,442
- GENERAL EP$25,351
- Carto 3$23,969
- ACUSON SC2000 Diagnostic Ultrasound System$23,780
- ACUSON Origin Diagnostic Ultrasound System$17,654
- GENERAL - THERAPIES$8,694
- IGT Devices Und$6,250
- Farapulse$5,363
- (9525) Intracardiac Und$4,469
- AVEIR$2,992
- Rhythmia Mapping System$1,979
- EMBLEM$897
- Ensite Cardiac Mapping System$785
- AFFERA MAPPING SYSTEM$640
- Thermocool SF$625
- WATCHMAN FLX$410
- (9124) LM Undivided$393
- WATCHMAN Access System$371
- Intracardiac Undivided$219
- ViewMate Intracardiac Echo$148
How this compares
$187,534 in reported general payments places this provider in the 95th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
See all clinical cardiac electrophysiology providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 380 | $477,420 |
| XareltoRivaroxaban | 113 | $129,777 |
| Dofetilide | 96 | $22,221 |
| Quinidine Sulfate | 12 | $9,198 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 24 | $7,074 |
| Flecainide Acetate | 170 | $5,622 |
| Propafenone Hcl | 17 | $2,736 |
| Amiodarone Hcl | 172 | $2,039 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 63 | $1,410 |
| SotalolSotalol Hcl | 48 | $1,213 |
| Metoprolol Succinate | 136 | $1,135 |
| Potassium Chloride | 17 | $432 |
| Metoprolol Tartrate | 78 | $422 |
| Warfarin Sodium | 21 | $363 |
| Propranolol Hcl ErPropranolol Hcl | 20 | $282 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $14 | $129,777113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
Other clinical cardiac electrophysiology in Columbus
- Anish AminColumbus$1.1M
- John HummelColumbus$275K
- Ralph AugostiniColumbus$174K
- David NemerColumbus$97K
- Eugene FuColumbus$96K
- Ankur ShahColumbus$75K
- Sampath GundaColumbus$73K
- Sreedhar BillakantyColumbus$64K
- Salvatore SavonaColumbus$49K
- Natee SirinvaravongColumbus$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.